Jan 19,2016

Insulet Raises Funds for Continued Diabetes Research

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System (OmniPod System), today announced that is has donated $10,000 each to the American Diabetes Association (ADA) and the Juvenile Diabetes Research Foundation (JDRF).

View Analyst & Ambassador Comments
Go to original news
Jan 20,2016

Brighter is negotiating agreements with 5 mobile operators

Northern Europe and Southeast Asia could become the first markets for subscription services agreements for Brighter's® integrated and connected aid for insulin-treated diabetics, Actiste™. Negotiations have begun and the agreement is expected to be concluded during the first half of 2016.

PRODUCT

#mobile app

View Analyst & Ambassador Comments
Go to original news
Jan 25,2016

Insulet Corporation to Announce Fourth Quarter and Full Year 2015 Financial Results on February 25, 2016

Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced plans to release its financial results for the fourth quarter and full year 2015 on February 25, 2016 after the close of the financial markets. In connection with the release, management will host a conference call that day at 4:30 p.m. (Eastern Time).

View Analyst & Ambassador Comments
Go to original news
Jan 25,2016

Fit4D (now named as Cecelia Health) Launches with Acacia Health Network

Fit4D (now named as Cecelia Health) announced today that it launched its innovative diabetes platform to members of Acacia Network’s Integrated Service Delivery System. Acacia Network is the second largest Latino non-profit in the country and its network of integrated services provides care for a largely underserved Latino population in NYC, Albany and Buffalo, NY.

COLLABORATION PARTNERSHIP

#institution

View Analyst & Ambassador Comments
Go to original news
Jan 26,2016

LabStyle Innovations to Launch Dario Blood Glucose Monitoring System in the U.S. in Q1 2016

LabStyle Innovations Corp. (OTCQB: DRIO), developer of the Dario™ Blood Glucose Monitoring System, today announced it is preparing to launch its FDA-cleared product in the United States in the first quarter of 2016. The national rollout in the U.S. follows the FDA's 510(k) clearance of the Dario in December 2015.

PRODUCT

#bgm

View Analyst & Ambassador Comments
Go to original news
Feb 04,2016

Ahead of IPO, Senseonics taps diasend for CGM app integration

Senseonics recently announced a partnership with diasend, a Swedish diabetes data management company. Diasend integrates data from a number of different glucometers, CGMs, and insulin pumps and pulls that data into a consumer app for Apple and Android.

COLLABORATION PARTNERSHIP

#connected device

#cgm

View Analyst & Ambassador Comments
Go to original news
Feb 08,2016

In small study, learning algorithm helps diabetes patients be more active

A small study published in Diabetes Care, the journal of the American Diabetes Association, shows that personalized text messages with positive and negative feedback are more effective than texts that are simply reminders.

CLINICAL STUDY
View Analyst & Ambassador Comments
Go to original news
Feb 18,2016

Omada Health launches new version of Prevent with features for underserved populations

San Francisco-based Omada Health has launched a new version of its Prevent program with additional features designed for underserved populations, which include people who are Medicaid enrolled, Medicaid eligible but uninsured, as well as clinical trials for the product. Users are paired with a health coach who monitors their progress throughout the program. Each week, users take an interactive health lesson that covers a range of topics including exercise and nutrition on a mobile device or computer. As part of the program, users receive a wireless-enabled scale and pedometer so that they can track their progress digitally.

PRODUCT

#dtx

#mobile app

View Analyst & Ambassador Comments
Go to original news
Feb 01,2016

Ascensia Diabetes Care to Attend 9th International Conference on Advanced Technologies & Treatments for Diabetes, Their First Congress Since Company Launch

Ascensia Diabetes Care today announced that they will be attending the 9th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD) later this week. The ATTD 2016 has been chosen as the first global conference where Ascensia Diabetes Care will be present since the close of the sale of the Diabetes Care business from Bayer AG to Panasonic Healthcare Holdings Co., Ltd., which was announced on 5 January 2016. The ATTD is taking place on 3-6 February 2016 in Milan, Italy.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Feb 01,2016

Brighter receives SEK 11.4 million through the use of warrants

After the end of the subscription period for warrants of series 1 ("TO 1") and series 2 ("TO 2") in Brighter AB (publ), the result has been that 3,812,962 shares have been newly subscribed, meaning that approximately SEK 11.4 million will be added to the company.

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES